Márk Plander Selected Research

Márk Plander Research Topics

6	Multiple Myeloma 01/2022 - 03/2019
3	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 03/2023 - 10/2012
3	Essential Thrombocythemia 01/2018 - 11/2011
2	Disease Progression 03/2023 - 01/2021
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2023 - 10/2009
2	Residual Neoplasm 03/2019 - 10/2012
2	Primary Myelofibrosis (Myelosclerosis) 01/2018 - 11/2011
2	Neoplasms (Cancer) 11/2011 - 10/2009
1	Trisomy (Trisomies) 01/2021
1	Myocardial Infarction 02/2016
1	Hemorrhage 02/2016
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 10/2012
1	Polycythemia Vera 11/2011
1	Thrombosis (Thrombus) 11/2011
1	Lymphoma (Lymphomas) 10/2009
1	Sepsis (Septicemia) 10/2009

4	Lenalidomide (CC 5013)FDA Link 10/2021 - 10/2019
3	Dexamethasone (Maxidex)FDA LinkGeneric 01/2021 - 10/2009
2	Rituximab (Mabthera)FDA Link 03/2023 - 10/2009
2	ixazomibIBA 01/2021 - 10/2019
2	Proteasome InhibitorsIBA 01/2021 - 01/2021
2	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 11/2011
1	venetoclaxIBA 03/2023
1	Enhancer of Zeste Homolog 2 ProteinIBA 01/2023
1	pomalidomideIBA 01/2022
1	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 01/2021
1	ibrutinibIBA 01/2021
1	daratumumabIBA 11/2019
1	Monoclonal AntibodiesIBA 11/2019
1	InterferonsIBA 02/2016
1	AcidsIBA 02/2016
1	Hydroxyurea (Hydrea)FDA LinkGeneric 02/2016
1	CalreticulinIBA 02/2016
1	anagrelide (Agrylin)FDA LinkGeneric 02/2016
1	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2012
1	fludarabineIBA 10/2012
1	Janus Kinase 2IBA 11/2011
1	Methotrexate (Mexate)FDA LinkGeneric 10/2009
1	thiamine triphosphorate (TTP)IBA 10/2009
1	Leucovorin (Folinic Acid)FDA Link 10/2009

5	Therapeutics 03/2023 - 10/2009
2	Salvage Therapy 01/2021 - 10/2009
1	Aftercare (After-Treatment) 03/2019
1	Splenectomy 10/2012
1	Radiotherapy 10/2009
1	Drug Therapy (Chemotherapy) 10/2009
1	Combination Drug Therapy (Combination Chemotherapy) 10/2009
1	VAP-cyclo protocol 10/2009